Gerhard Heil

10.9k citations

122 papers · 6.9k · 3 hit papers · h-index 38

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 84
- Acute Myeloid Leukemia Research 77
- Hematopoietic Stem Cell Transplantation 22
- Chronic Myeloid Leukemia Treatments 15
Public Health, Environmental and Occupational Health 29
- Acute Lymphoblastic Leukemia research 29

Co-authors: Arnold Ganser (67 shared papers)Jürgen Krauter (29 shared papers)Hartmut Döhner (14 shared papers)Brigitte Schlegelberger (14 shared papers)Konstanze Döhner (9 shared papers)Dieter Hoelzer (16 shared papers)Michael Morgan (6 shared papers)Wolfram Brugger (24 shared papers)
Journals: Blood (38 papers)Annals of Hematology (17 papers)Journal of Clinical Oncology (14 papers)British Journal of Haematology (6 papers)Leukemia (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Gerhard Heil

116 papers receiving 6.7k citations

Gerhard Heil's Hit Papers

align trajectories log scale

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial 2013 · 985 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 The Lancet
2008 New England Journal of Medicine
1988 Blood

Peers

Countries citing papers authored by Gerhard Heil

Since Specialization

Citations

This map shows the geographic impact of Gerhard Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Heil more than expected).

Fields of papers citing papers by Gerhard Heil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Heil. The network helps show where Gerhard Heil may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerhard Heil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerhard Heil Line = papers co-authored together Gerhard Heil links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia New England Journal of Medicine ·Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter, Stefan Fröhling, Andrea Corbacioglu, Lars Bullinger, Marianne Habdank, Daniela Späth, Michael Morgan, Axel Benner, Brigitte Schlegelberger, Gerhard Heil, Arnold Ganser, Hartmut Döhner Hit paper breakdown →	2008	1112
2	Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial The Lancet ·Mathias Rummel, N. Niederle, Georg Maschmeyer, Gamal-Andre Banat, Ulrich von Grünhagen, Christoph Losem, Dorothea Kofahl-Krause, Gerhard Heil, Manfred Welslau, Christina Balser, Ulrich Kaiser, Eckhart Weidmann, Heinz Dürk, Harald Balló, Martina Stauch, Fritz Roller, Juergen Barth, Dieter Hoelzer, Axel Hinke, Wolfram Brugger Hit paper breakdown →	2013	985
3	Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults Blood ·D. Hoelzer, E. Thiel, H. Löffler, Th. Büchner, Arnold Ganser, Gerhard Heil, P. Koch, Mathias Freund, H. Diedrich, Heiko Rühl Hit paper breakdown →	1988	431
4	Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial Journal of Clinical Oncology ·Helmut Oettle, Hanno Riess, Jens Stieler, Gerhard Heil, Ingo Schwaner, Jörg Seraphin, Martin Görner, Matthias Mölle, Tim F. Greten, Volker Lakner, Sven Bischoff, Marianne Sinn, Bernd Dörken, Uwe Pelzer	2014	321
5	Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia Journal of Clinical Oncology ·Felicitas Thol, Frédérik Damm, Andrea Lüdeking, Claudia Winschel, Katharina Wagner, Michael Morgan, Haiyang Yun, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer, Michael Lübbert, Lothar Kanz, Walter Fiedler, Hartmut Kirchner, Gerhard Heil, Jürgen Krauter, Arnold Ganser, Michael Heuser	2011	277
6	Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup Journal of Clinical Oncology ·R. Schlenk, Axel Benner, J Krauter, Thomas Büchner, Cristina Sauerland, Gerhard Ehninger, Markus Schaich, Brigitte Mohr, Dietger Niederwieser, Rainer Krahl, R. Pasold, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Gerhard Heil	2004	245
7	A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia Blood ·Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz, Klaus Lechner, John A. Liu Yin, Giuseppe Francesco Sferrazza Papa, L. Noens, Jeff Szer, Arnold Ganser, Caroline O’Brien, James Matcham, Alan Barge	1997	232
8	Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor Journal of Clinical Oncology ·Katharina Wagner, Frédérik Damm, Gudrun Göhring, Kerstin Görlich, Michael Heuser, Irina Schäfer, Oliver G. Ottmann, Michael Lübbert, W. Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Wolfram Brugger, Manuela Zucknick, Brigitte Schlegelberger, Gerhard Heil, Arnold Ganser, Jürgen Krauter	2010	183
9	A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy Haematologica ·Michael Lübbert, Björn Rüter, Rainer Claus, Claudia Schmoor, Mathias Schmid, Ulrich Germing, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, Uwe Platzbecker, Oliver Galm, Wolfram Brugger, Gerhard Heil, Björn Hackanson, Barbara Deschler-Baier, Konstanze Döhner, A Hagemeijer, P. Wijermans, Hartmut Döhner	2011	172
10	AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells Blood ·Olaf Heidenreich, Jürgen Krauter, Heidemarie Riehle, Philipp Hadwiger, Matthias John, Gerhard Heil, Hans‐Peter Vornlocher, Alfred Nordheim	2003	135
11	Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia Blood ·Felicitas Thol, Frédérik Damm, Katharina Wagner, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer, Michael Lübbert, W. Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Gerhard Heil, Michael Heuser, Jürgen Krauter, Arnold Ganser	2010	134
12	Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood ·Wolfgang Ludwig, Harald Rieder, Claus R. Bartram, B Heinze, Stefan Schwartz, W. Gaßmann, Helmut Löffler, Dieter K. Hossfeld, Gerhard Heil, Susanne Handt, A. Heyll, H. Diedrich, Konstanze Fischer, A. Weiss, B. Völkers, Ü. Aydemir, Christa Fonatsch, Nicola Gökbuget, Eckhard Thiel, Dieter Hoelzer	1998	132
13	Bendamustine Plus Rituximab Is Superior in Respect of Progression Free Survival and CR Rate When Compared to CHOP Plus Rituximab as First-Line Treatment of Patients with Advanced Follicular, Indolent, and Mantle Cell Lymphomas: Final Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany). Blood ·Mathias Rummel, N. Niederle, Georg Maschmeyer, A. Banat, Ulrich von Gruenhagen, Christoph Losem, Gerhard Heil, Manfred Welslau, Christina Balser, Ulrich Kaiser, Harald Balló, Eckhart Weidmann, Heinz A. Duerk, Dorothea Kofahl-Krause, Fritz Roller, Juergen Barth, Dieter Hoelzer, Axel Hinke, Wolfram Brugger	2009	113
14	Prognostic Value of Minimal Residual Disease Quantification by Real-Time Reverse Transcriptase Polymerase Chain Reaction in Patients With Core Binding Factor Leukemias Journal of Clinical Oncology ·Jürgen Krauter, Kerstin Görlich, Oliver G. Ottmann, Michael Lübbert, Hartmut Döhner, W. Heit, Lothar Kanz, Arnold Ganser, Gerhard Heil	2003	102
15	A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study Journal of Clinical Oncology ·Uwe Pelzer, Krystian Kubica, Jens Stieler, Ingo Schwaner, Gerhard Heil, Martin Görner, Mattia Fabio Molle, Andreas Hilbig, Bernd Dörken, Hanno Riess, Helmut Oettle	2008	100
16	Single Nucleotide Polymorphism in the Mutational Hotspot ofWT1Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia Journal of Clinical Oncology ·Frédérik Damm, Michael Heuser, Michael Morgan, Haiyang Yun, Anika Großhennig, Gudrun Göhring, Brigitte Schlegelberger, Konstanze Döhner, Oliver G. Ottmann, Michael Lübbert, W. Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Hartmut Döhner, Gerhard Heil, Arnold Ganser, Jürgen Krauter	2009	94
17	Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial Blood ·Oliver G. Ottmann, D. Hoelzer, Edith Gracien, Arnold Ganser, Karen Kelly, Regina Reutzel, T. Lipp, F. W. Busch, Martin Schwonzen, Gerhard Heil	1995	90
18	A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia Blood ·E Archimbaud, Oliver G. Ottmann, John A. Liu Yin, Klaus Lechner, Hervé Dombret, Miguel Á. Sanz, Gerhard Heil, Pierre Fenaux, Wolfram Brugger, Alan Barge, Caroline O’Brien-Ewen, James Matcham, Dieter Hoelzer	1999	83
19	Integrative prognostic risk score in acute myeloid leukemia with normal karyotype Blood ·Frédérik Damm, Michael Heuser, Michael Morgan, Katharina Wagner, Kerstin Görlich, Anika Großhennig, Iyas Hamwi, Felicitas Thol, Ewa Surdziel, Walter Fiedler, Michael Lübbert, Lothar Kanz, Christoph Reuter, Gerhard Heil, Ruud Delwel, Bob Löwenberg, Peter J.M. Valk, Jürgen Krauter, Arnold Ganser	2011	81
20	Analysis of Concerted Expression of Angiogenic Growth Factors in Acute Myeloid Leukemia: Expression of Angiopoietin-2 Represents an Independent Prognostic Factor for Overall Survival Journal of Clinical Oncology ·Sonja Loges, Gerhard Heil, Melanie Bruweleit, Volker Schoder, Martin Butzal, Uta Fischer, Ursula M. Gehling, Gunter Schuch, Dieter K. Hossfeld, Walter Fiedler	2005	76

About Gerhard Heil

Gerhard Heil is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Genetics, having authored 122 papers that have together received 6.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (77 papers), Acute Lymphoblastic Leukemia research (29 papers), Hematopoietic Stem Cell Transplantation (22 papers), Lymphoma Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Neutropenia and Cancer Infections (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Hematology (3.9k citations), Genetics (1.6k citations), Pathology and Forensic Medicine (1.3k citations), Oncology (1.9k citations) and Public Health, Environmental and Occupational Health (1.4k citations). Gerhard Heil has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Arnold Ganser, Jürgen Krauter, Hartmut Döhner, Brigitte Schlegelberger, Konstanze Döhner, Dieter Hoelzer, Michael Morgan, Wolfram Brugger, Axel Benner and Richard F. Schlenk. Their work appears in journals such as Blood, Annals of Hematology, Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gerhard Heil

Impact in

Papers in i

In The Last Decade

Gerhard Heil

Gerhard Heil's Hit Papers

Peers

Countries citing papers authored by Gerhard Heil

Fields of papers citing papers by Gerhard Heil

All Works

About Gerhard Heil

Explore authors with similar magnitude of impact

Papers in